APA ציטוט

Kontsekova, E., Zilka, N., Kovacech, B., Novak, P., & Novak, M. (2014). First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model. Alzheimers Res Ther.

Citação norma Chicago

Kontsekova, Eva, Norbert Zilka, Branislav Kovacech, Petr Novak, and Michal Novak. "First-in-man Tau Vaccine Targeting Structural Determinants Essential for Pathological Tau–tau Interaction Reduces Tau Oligomerisation and Neurofibrillary Degeneration in an Alzheimer’s Disease Model." Alzheimers Res Ther 2014.

ציטוט MLA

Kontsekova, Eva, et al. "First-in-man Tau Vaccine Targeting Structural Determinants Essential for Pathological Tau–tau Interaction Reduces Tau Oligomerisation and Neurofibrillary Degeneration in an Alzheimer’s Disease Model." Alzheimers Res Ther 2014.

אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.